* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
DNA Myoglobin Protein 4.93 nM (reported value)20 mM Hepes, 120 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1mM
MgCl2, pH 7.3N/A
If the oligo is a known aptamer sequence: For binding studies, perform a refolding program to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Wang, Q., et al. “Sensitive point-of-care monitoring of cardiac biomarker myoglobin using aptamer and ubiquitous person glucose meter.” Biosensors and Bioelecgtronics, 64 (2015): 161-164.
Wang, Q., et al. “Screening of DNA Aptamers against Myoglobin Using a Positive and Negative Selection Units Integrated Microfluid Chip and its Biosensing Application.” Analytical Chemistry, 86 (2014): 6572-6579.
Have your aptamer oligo synthesized by one of our AFFILIATES
* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
DNA
Myoglobin
Protein
4.93 nM (reported value)
20 mM Hepes, 120 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1mM
MgCl2, pH 7.3
N/A
If the oligo is a known aptamer sequence: For binding studies, perform a refolding program to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
